Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
DANAHER CORP /DE/ (DHR) reported revenue of $6.26B and net income of $870.00M for the fiscal year ended 2026-06-26. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from DANAHER CORP /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Instruments For Measurement, Display, and Control.
Income
| Metric | 2026-06-26 | 2026-03-27 | 2025-12-31 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-31 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B |
| Cost of revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.32B | $2.31B |
| Gross profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B |
| Operating income | $1.13B | $1.34B | $1.50B | $1.15B | $760.00M | $1.27B | $1.42B | $958.00M | $1.17B | $1.31B |
| Net income | $870.00M | $1.03B | $1.20B | $908.00M | $555.00M | $954.00M | $1.09B | $818.00M | $907.00M | $1.09B |
| Research & development | $412.00M | $387.00M | $438.00M | $378.00M | $403.00M | $379.00M | $442.00M | $383.00M | $391.00M | $368.00M |
| Weighted-average diluted shares | shares 707.60M | shares 711.20M | Unavailable | shares 713.70M | shares 719.10M | shares 720.80M | Unavailable | shares 729.40M | shares 742.40M | shares 748.60M |
| Pretax income | $1.08B | $1.24B | $1.37B | $1.08B | $655.00M | $1.13B | $1.32B | $977.00M | $1.08B | $1.27B |
| Income tax expense | $208.00M | $206.00M | $190.00M | $168.00M | $100.00M | $175.00M | $229.00M | $159.00M | $176.00M | $183.00M |
| Diluted EPS | $1.23 | $1.45 | Unavailable | $1.27 | $0.77 | $1.32 | Unavailable | $1.12 | $1.22 | $1.45 |
| Selling, general & administrative | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-26 | 2026-03-27 | 2025-12-31 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-31 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.62B | $78.56B | $83.40B |
| Current assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.52B | $9.50B | $10.06B | $9.61B | $14.37B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $8.10B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B |
| Total equity incl. NCI | $52.59B | $52.96B | $52.54B | $51.08B | $52.34B | $50.86B | $49.55B | $51.30B | $49.90B | $53.45B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.64B |
| Accounts receivable | $3.96B | $3.82B | $3.91B | $3.76B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B |
| Goodwill | $47.41B | $42.76B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B |
| Long-term debt | $25.15B | $17.56B | $18.42B | $16.83B | $16.85B | $15.98B | $15.50B | $16.32B | $16.31B | $16.42B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-26 | 2026-03-27 | 2025-12-31 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-31 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B |
| Capital expenditures | $269.00M | $237.00M | $371.00M | $292.00M | $248.00M | $245.00M | $516.00M | $298.00M | $287.00M | $291.00M |
| Investing cash flow | -$10.15B | -$249.00M | -$384.00M | -$312.00M | -$258.00M | -$242.00M | -$694.00M | -$606.00M | -$360.00M | -$321.00M |
| Financing cash flow | $7.27B | $46.00M | $1.32B | -$2.78B | -$247.00M | -$1.26B | -$1.69B | -$845.00M | -$5.72B | -$133.00M |
| Net change in cash | -$1.35B | $1.09B | $3.09B | -$1.43B | $964.00M | -$85.00M | -$549.00M | $253.00M | -$4.66B | $1.17B |
| Stock-based compensation | $93.00M | $58.00M | $63.00M | $83.00M | $91.00M | $61.00M | $57.00M | $84.00M | $87.00M | $60.00M |
| Common dividends paid | $283.00M | $226.00M | $226.00M | $229.00M | $229.00M | $194.00M | $195.00M | $196.00M | $200.00M | $177.00M |
| Common share repurchases | $894.00M | $0 | $0 | $2.01B | $0 | $1.08B | $809.00M | $640.00M | $4.53B | $0 |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-26 | 2026-03-27 | 2025-12-31 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-31 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.26B | $1.08B | $1.75B | $1.37B | $1.09B | $1.05B | $1.50B | $1.22B | $1.13B | $1.45B |
| Gross margin | 57.6% | 60.3% | 58.0% | 58.2% | 59.3% | 61.2% | 59.5% | 58.7% | 59.7% | 60.2% |
| Operating margin | 18.0% | 22.6% | 22.0% | 19.1% | 12.8% | 22.2% | 21.8% | 16.5% | 20.3% | 22.6% |
| FCF margin | 20.2% | 18.2% | 25.5% | 22.6% | 18.4% | 18.4% | 23.0% | 21.0% | 19.7% | 25.0% |
| SBC / revenue | 1.5% | 1.0% | 0.9% | 1.4% | 1.5% | 1.1% | 0.9% | 1.4% | 1.5% | 1.0% |
| Current ratio | 1.65x | 1.87x | 1.87x | 1.52x | 1.62x | 1.43x | 1.40x | 1.37x | 1.43x | 1.85x |
| Revenue YoY growth | 5.5% | 3.7% | 4.6% | 4.4% | 3.4% | -0.9% | 2.1% | 3.1% | -2.9% | -2.6% |
| Net margin | 13.9% | 17.3% | 17.5% | 15.0% | 9.3% | 16.6% | 16.6% | 14.1% | 15.8% | 18.8% |
| R&D / revenue | 6.6% | 6.5% | 6.4% | 6.2% | 6.8% | 6.6% | 6.8% | 6.6% | 6.8% | 6.3% |
| CapEx / revenue | 4.3% | 4.0% | 5.4% | 4.8% | 4.2% | 4.3% | 7.9% | 5.1% | 5.0% | 5.0% |
| Long-term debt / equity | 0.48x | 0.33x | 0.35x | 0.33x | Unavailable | Unavailable | 0.31x | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 19.3% | 16.7% | 13.8% | 15.6% | 15.3% | 15.5% | 17.4% | 16.3% | 16.3% | 14.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DHR in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.